Patent · US Expired

Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis

US5602096A · kind A · utility

9Cited by
1References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 6, 1995
Grant dateFeb 11, 1997
Priority date
Expiry dateJun 6, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/026
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is the characterization and purification of DNA encoding numerous polypeptides useful for the stimulation of glial cell (particularly, Schwann cell mitogenesis and treating glial cell tumors. Also disclosed are DNA sequences encoding novel polypeptides which may have use in stimulating glial cell mitogenesis and treating glial cell tumors. Methods for the synthesis, purification and testing of both known and novel polypeptides for their use as both therapeutic and diagnostic aids in the treatment of diseases involving glial cells are also provided. Methods are also provided for the use of these polypeptides for the preparation of antibody probes useful for both diagnostic and therapeutic use in diseases involving glial cells. The present invention is specifically directed to a method of using a secretable glial growth factor to induce acetycholine receptor synthesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.